Activation of thromboxane A2 receptors mediates endothelial dysfunction in diabetic mice

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Clinical and experimental hypertension

• Publication date

  2017-05-17

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1080/10641963.2016.1246558PMID 28513223
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Activation of activator protein 2 alpha by aspirin alleviates atherosclerotic plaque growth and instability in vivo

  2016cited by this paper
• Berberine via suppression of transient receptor potential vanilloid 4 channel improves vascular stiffness in mice

  2015cited by this paper
• Rosiglitazone via PPARγ-dependent suppression of oxidative stress attenuates endothelial dysfunction in rats fed homocysteine thiolactone

  2015cited by this paper
• Vitamin B6 Prevents Endothelial Dysfunction, Insulin Resistance, and Hepatic Lipid Accumulation in Apoe −/− Mice Fed with High-Fat Diet

  2015cited by this paper
• Inhibition of NA+/H+ Exchanger 1 Attenuates Renal Dysfunction Induced by Advanced Glycation End Products in Rats

  2015cited by this paper
• Type 2 Diabetes: Endothelial dysfunction and Exercise

  2014cited by this paper
• Insulin Resistance, Diabetes, and Cardiovascular Risk

  2014cited by this paper
• Endothelial dysfunction in diabetes: pathogenesis, significance, and treatment.

  2013cited by this paper
• Hyperglycemia-induced oxidative stress and its role in diabetes mellitus related cardiovascular diseases.

  2013cited by this paper
• Dietary advanced glycation end-product restriction for the attenuation of insulin resistance, oxidative stress and endothelial dysfunction: a systematic review

  2013cited by this paper
• Activation of AMP-activated protein kinase α2 by nicotine instigates formation of abdominal aortic aneurysms in mice in vivo

  2012cited by this paper
• Inhibition of the AMP-Activated Protein Kinase-&agr;2 Accentuates Agonist-Induced Vascular Smooth Muscle Contraction and High Blood Pressure in Mice

  2011cited by this paper
• AMPK&agr;2 Deletion Causes Aberrant Expression and Activation of NAD(P)H Oxidase and Consequent Endothelial Dysfunction In Vivo: Role of 26S Proteasomes

  2010cited by this paper
• In Vivo Activation of AMP-Activated Protein Kinase Attenuates Diabetes-Enhanced Degradation of GTP Cyclohydrolase I

  2009cited by this paper
• Mammalian Rho GTPases: new insights into their functions from in vivo studies

  2008cited by this paper
• Na+/H+ exchanger is required for hyperglycaemia-induced endothelial dysfunction via calcium-dependent calpain.

  2008cited by this paper
• Prostanoid signal transduction and gene expression in the endothelium: role in cardiovascular diseases.

  2006cited by this paper
• Rho Kinase Inhibition Improves Endothelial Function in Human Subjects With Coronary Artery Disease

  2006cited by this paper
• Free Fatty Acids Inhibit Insulin Signaling–Stimulated Endothelial Nitric Oxide Synthase Activation Through Upregulating PTEN or Inhibiting Akt Kinase

  2006cited by this paper
• Diabetes Mellitus Receptor Antagonist S 18886 Prevents Enhanced Atherogenesis 2 The Thromboxane

  2005cited by this paper
• Thromboxane A2 and prostaglandin F2alpha mediate inflammatory tachycardia.

  2005cited by this paper
• Thromboxane A2 and prostaglandin F2α mediate inflammatory tachycardia

  2005cited by this paper
• Thromboxane A2 Receptor Signaling Inhibits Vascular Endothelial Growth Factor–Induced Endothelial Cell Differentiation and Migration

  2004cited by this paper
• Roles of thromboxane A(2) and prostacyclin in the development of atherosclerosis in apoE-deficient mice.

  2004cited by this paper
• Roles of thromboxane A2 and prostacyclin in the development of atherosclerosis in apoE-deficient mice

  2004cited by this paper
• Rho GTPase/Rho Kinase Negatively Regulates Endothelial Nitric Oxide Synthase Phosphorylation through the Inhibition of Protein Kinase B/Akt in Human Endothelial Cells

  2002cited by this paper
• Nitrotyrosine causes selective vascular endothelial dysfunction and DNA damage.

  2000cited by this paper
• Reversal of angiogenesis in vitro, induction of apoptosis, and inhibition of AKT phosphorylation in endothelial cells by thromboxane A(2).

  2000cited by this paper
• Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation

  1999cited by this paper
• Rho GTPases Control Polarity, Protrusion, and Adhesion during Cell Movement

  1999cited by this paper
• Regulation of endothelium-derived nitric oxide production by the protein kinase Akt

  1999cited by this paper
• Major Histocompatibility Complex Class I–Restricted Infiltration and Destruction of Pancreatic Islets by NOD Mouse-Derived β-Cell Cytotoxic CD8+ T-Cell Clones In Vivo

  1996cited by this paper
• Development and consequences of insulin resistance: lessons from animals with hyperinsulinaemia.

  1996cited by this paper
• Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia.

  1995cited by this paper

• Thromboxane A2 blockade attenuates ethanol-induced myocardial inflammation: Sipping from the same bottle.

  2024cites this paper
• Blocking Thromboxane-Prostanoid Receptor Signaling Attenuates Lipopolysaccharide- and Stearic Acid-Induced Inflammatory Response in Human PBMCs

  2024cites this paper
• Tree of life: endothelial cell in norm and disease, the good guy is a partner in crime!

  2023cites this paper
• Chronic cyclooxygenase-2 inhibition prevents the worsening of hypertension and endothelial dysfunction induced by ouabain in resistance arteries of spontaneously hypertensive rats.

  2021cites this paper
• Pemafibrate, A Novel Selective Peroxisome Proliferator-Activated Receptor α Modulator, Reduces Plasma Eicosanoid Levels and Ameliorates Endothelial Dysfunction in Diabetic Mice

  2021cites this paper
• Thromboxane A2 synthase inhibition ameliorates endothelial dysfunction, memory deficits, oxidative stress and neuroinflammation in rat model of streptozotocin diabetes induced dementia.

  2021cites this paper
• Repurposing of a Thromboxane Receptor Inhibitor Based on a Novel Role in Metastasis Identified by Phenome-Wide Association Study

  2020cites this paper
• DIABETES MELLITUS AND PULMONARY CIRCULATION (PART 2)

  2019cites this paper
• Evaluating maternal hyperglycemic exposure and fetal placental arterial dysfunction in a dual cotyledon, dual perfusion model.

  2018cites this paper